FIELD: medicine, diagnostics of malignant neoplasms, clinical biochemistry.
SUBSTANCE: method of diagnosing cervical cancer based on the level of E-cadherin in blood plasma in non-linear rats includes blood sampling followed by obtaining plasma and conducting enzyme immunoassay. The concentration of E-cadherin is determined and expressed in pg/ml. If the concentration of E-cadherin is more than 3.43 pg/ml, cervical cancer is diagnosed.
EFFECT: invention makes it possible to increase the efficiency of diagnosing oncological processes of the cervix.
1 cl, 5 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF III DEGREE AND PRE-INVASIVE CERVICAL CANCER, ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2012 |
|
RU2506892C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF GRADE III AND MICROINVASIVE CERVICAL CANCER ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2019 |
|
RU2735660C1 |
| METHOD OF DIAGNOSTICS OF UTERI CERVIX CANCER | 2007 |
|
RU2343485C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CERVICAL DYSPLASIA AND CERVICAL CANCER | 2012 |
|
RU2538618C2 |
| METHOD FOR EARLY DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS (CIN) BASED ON METABOLIC MARKERS STUDY | 2016 |
|
RU2629632C1 |
| METHOD OF PREDICTING UNFAVOURABLE COURSE OF LOCALLY SPREAD FORMS OF HUMAN PAPILLOMA VIRUS-ASSOCIATED CERVICAL CANCER | 2012 |
|
RU2504326C1 |
| DIAGNOSTIC TECHNIQUE FOR DEGREE OF CERVICAL DYSPLASIA | 2019 |
|
RU2704966C1 |
| METHOD OF PREDICTION OF PROBABILITY OF CERVICAL CANCER DETECTION BASED ON ROUTINE BLOOD PARAMETERS | 2023 |
|
RU2802395C2 |
| METHOD FOR DYNAMIC CONTROL OF EFFICIENCY OF TREATMENT OF CERVICAL INTRAEPITHELIAL LESIONS OF CERVIX UTERI BY MEANS OF DIINDOLYLMETHANE-BASED SUPPOSITORIES | 2015 |
|
RU2618427C1 |
| METHOD OF PREVENTION AND TREATMENT OF CERVICAL STENOSIS AFTER SURGICAL TREATMENT | 2023 |
|
RU2797111C2 |
